Spots Global Cancer Trial Database for Tranexamic Acid After Pathological Fracture Treated With Modular Arthroplasty
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Tranexamic Acid After Pathological Fracture Treated With Modular Arthroplasty
Official Title: Tranexamic Acid After Pathological Fracture Treated With Modular Arthroplasty: Retrospective Observational Study
Study ID: NCT06244498
Conditions
Interventions
Study Description
Brief Summary: This study assesses the safety and efficacy of TXA for patients treated for pathological femur fractures using modular prosthetics.
Detailed Description: Tranexamic acid is an efficacious medication for curtailing blood loss, haemoglobin drop, and the requirement for transfusions. Additionally, it is a secure medication, even when administered to oncology patients receiving reduction haemarthroplasty for pathological femoral fractures.
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
SzSPOO Brzozów, Brzozów, Podkarpackie, Poland
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
